Sanofi and Regeneron's high-flying Dupixent tops May pharma TV spending, trading places with AbbVie's Humira

Sanofi and Regeneron’s asthma and eczema drug climbed back to No. 1 in May, while AbbVie’s blockbuster anti-inflammatory dropped again to second, according to data from real-time TV ad tracker iSpot.tv.